Literature DB >> 2218652

Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy.

C B Seelig1, P A Maloley, J R Campbell.   

Abstract

Angiotensin-I converting enzyme (ACE) inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) can be nephrotoxic and may synergistically compromise renal function. A computer-assisted study was done to asses the prevalence of compromised renal function and the clinical importance of this drug interaction. A search of the records of all patients seen in the University of Nebraska Medical Center Internal Medicine Clinic was conducted to identify cases involving renal insufficiency, therapy with ACE inhibitors, or therapy with NSAIDs. Records of cases meeting these criteria were reviewed for clinical correlation and revealed 2278 patients treated with NSAIDs, 328 with ACE inhibitors, and 162 with both. No nephrotoxicity was found in conjunction with monotherapy, but three cases of reversible renal failure were found in conjunction with combination therapy. Significant nephrotoxicity during the concomitant use of ACE inhibitors and NSAIDs is not uncommon, and attention should be drawn to this potentially important interaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2218652     DOI: 10.1097/00007611-199010000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  13 in total

Review 1.  Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment.

Authors:  W Ailabouni; G Eknoyan
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 2.  Fosinopril. Clinical pharmacokinetics and clinical potential.

Authors:  H Shionoiri; M Naruse; K Minamisawa; S Ueda; H Himeno; S Hiroto; I Takasaki
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Coadministration of Liposomal Amphotericin B and Contrast Medium Does Not Increase Risk of Kidney Injury.

Authors:  John C O'Horo; Douglas R Osmon; Omar M Abu Saleh; Jasmine R Marcelin; Kamel A Gharaibeh; Abdurrahman M Hamadah; Amelia K Barwise; Bryce M Kayhart; Jennifer S McDonald; Robert J McDonald; Nelson Leung
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 4.  ACE inhibitors. Drug interactions of clinical significance.

Authors:  C Mignat; T Unger
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 5.  ACE inhibitors in non-diabetic renal disease.

Authors:  R J Fluck; A E Raine
Journal:  Br Heart J       Date:  1994-09

Review 6.  [Drug interactions in pain therapy].

Authors:  K M J Syhr; B G Oertel; G Geisslinger
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

7.  Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs.

Authors:  V Adhiyaman; M Asghar; A Oke; A D White; I U Shah
Journal:  J R Soc Med       Date:  2001-10       Impact factor: 5.344

8.  The effect of tenidap on the anti-hypertensive efficacy of ACE inhibitors in patients treated for mild to moderate hypertension.

Authors:  W G Rapeport; V C Grimwood; J Hosie; P M Sloan; K Korlipara; B D Silvert; I James; G L Mechie; J L Anderton
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

Review 9.  Pharmacokinetic drug interactions with ACE inhibitors.

Authors:  H Shionoiri
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

Review 10.  Aspirin and other NSAIDs as chemoprevention agents in melanoma.

Authors:  James R Goodman; Douglas Grossman
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.